[Skip to Navigation]
Sign In
April 11, 2012

Statin Therapy for Healthy Men Identified as “Increased Risk”

Author Affiliations

Author Affiliations: The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, Maryland.

JAMA. 2012;307(14):1489-1490. doi:10.1001/jama.2012.425

Should a 55-year-old man who is otherwise well, with systolic blood pressure of 110 mm Hg, total cholesterol of 250 mg/dL, and no family history of premature CHD be treated with a statin?—Yes.

Atherosclerotic coronary heart disease (CHD) is the most common cause of morbidity and mortality in the world. The “lipid hypothesis” of CHD is clearly established: (1) circulating cholesterol plays a central role in atherogenesis and is an integral component of the requisite lesion, the coronary plaque; (2) cholesterol levels beginning in childhood predict lifetime risk of atherosclerotic CHD events in a dose-response relationship; and (3) statins lower cholesterol levels and reduce CHD and cerebrovascular events directly proportional to the degree of low-density lipoprotein cholesterol (LDL-C) lowering. As a result, guidelines from around the world support a combined lifestyle and pharmacologic approach to cholesterol lowering directed at patients with elevated CHD risk.

Add or change institution